✦ LIBER ✦

Recurrent rhabdomyosarcoma after adjuvant chemotherapy for stage I non-seminomatous germ cell tumor with malignant transformation

✍ Scribed by Ushida, Hiroshi; Koizumi, Shuichi; Katoh, Kenjiro; Okabe, Hidetoshi; Okada, Yusaku; Okamoto, Keisei

Book ID: 120650132
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 730 KB
Volume: 20
Category: Article
ISSN: 0919-8172
DOI: 10.1111/j.1442-2042.2012.03197.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non–Germ Cell Malignancy in Residual or

Non–Germ Cell Malignancy in Residual or Recurrent Mass After Chemotherapy for Nonseminomatous Testicular Germ Cell Tumor

✍ Martijn F. Lutke Holzik; Harald J. Hoekstra; Nanno H. Mulder; Albert J. H. Suurm 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 47 KB

884 Long-term results following one cour

884 Long-term results following one course of adjuvant chemotherapy for high-risk stage I non-seminomatous germ cell tumors: the Spanish germ cell cancer group experience

✍ X.Garcia del Muro; P. Maroto; A. Barnadas; J. Terrasa; A. Saenz; M. Lomas; J. Va 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Prognostic factors in patients with path

Prognostic factors in patients with pathological stage I non-seminomatous testicular germ cell tumors and tumor recurrence during follow-up

✍ Albers, P. ;DeRiese, W. T. ;Ulbright, T. M. ;Donohue, J. P. ;Foster, R. S. 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 338 KB

Clinical staging in patients with stage I nonseminomatous germ cell tumors (NSGCTs) of the testis fails in 30% to correctly assess pathological stage since microscopic and small-volume retroperitoneal disease is not detectable on computed tomography of the abdomen, Patients staged by retroperitoneal

Prognostic factors in patients progressi

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours

✍ Fosså, S D; Stenning, S P; Gerl, A; Horwich, A; Clark, P I; Wilkinson, P M; Jone 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 88 KB

N77 Risk-adapted management for patients

N77 Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumor of testis

✍ S. Güney; N. Güney; C. Sönmez; E. Ergenekon 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 57 KB

919 “Wait and see” policy for patients w

919 “Wait and see” policy for patients with clinical stage I non-seminomatous testicular germ cell tumors (NSTGCT)

✍ H. Schraffordt Koops; M.E. Gels; H.J. Hoekstra; D.Th. Sleijfer; J. Marrink; H.W. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 151 KB